Skip to content
Open access

Baseline Neutrophil-to-Lymphocyte Ratio and Longitudinal Lung Function Decline in Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

Oct 2026 · International Journal of COPD · Vol 21 · 0 citations · 39 references
Medicine

TL;DR

Higher baseline neutrophil-to-lymphocyte ratio was associated with modestly faster lung function decline after adjustment for disease severity, but the association depended on the adjustment model and does not establish causality or individual predictive value.

Abstract

Background Systemic inflammation may contribute to heterogeneous lung function trajectories in chronic obstructive pulmonary disease (COPD), but evidence linking the neutrophil-to-lymphocyte ratio (NLR) to longitudinal forced expiratory volume in one second (FEV1) change is limited. Methods We analyzed repeated spirometry from a single-center retrospective cohort. Eligibility required clinically stable chronic obstructive pulmonary disease, baseline blood counts, at least two qualified spirometry assessments, and at least 12 months of recorded follow-up. Linear mixed-effects models estimated the association between baseline log2-transformed neutrophil-to-lymphocyte ratio and annual forced expiratory volume in one second (FEV1) change. Sequential models added demographic and exposure variables, then baseline disease severity. Post hoc analyses examined common visit windows and sensitivity to covariate selection. Results Of 819 patients, 667 met longitudinal cohort criteria; 640 patients with 2525 qualified observations entered the complete-case model. Median recorded follow-up was 22 months, with a median of four qualified assessments per patient. Additional FEV1 decline per ratio doubling increased from 4.05 mL/year unadjusted (95% confidence interval −1.95 to 10.04) to 8.26 mL/year after severity adjustment (2.29 to 14.23; P=0.0068). Comparisons within the same 640 patients also showed model dependence. Restriction to baseline, 6-month and 12-month visit windows yielded 12.78 mL/year (2.72 to 22.84; 269 patients). The corresponding baseline, 12-month and 24-month estimate was imprecise (13.57 mL/year; −0.04 to 27.17; 116 patients). Conclusion Higher baseline neutrophil-to-lymphocyte ratio was associated with modestly faster lung function decline after adjustment for disease severity. The association depended on the adjustment model and does not establish causality or individual predictive value. Prospective studies with standardized follow-up are needed.

Read PDF

Similar papers

Open access Oct 2026

Association of Cardiovascular Disease with Exacerbations, Longitudinal Lung Function Changes, and Spirometric Transitions in Preserved Ratio Impaired Spirometry

Background Preserved ratio impaired spirometry (PRISm), defined as a post-bronchodilator forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) ratio ≥0.70 with a post-bronchodilator FEV1 <80% predicted, is a heterogeneous spirometric pattern associated with adverse clinical outcomes and progression...

Ruo-Bing Zhao, Ying-Xiang Lin · 0 citations
Open access Sep 2026

Nonlinear associations of the neutrophil-to-lymphocyte ratio and derived neutrophil-to-lymphocyte ratio with asthma–COPD overlap prevalence: a cross-sectional study

Background Asthma–chronic obstructive pulmonary disease overlap (ACO) is associated with persistent airflow limitation and adverse clinical outcomes. Whether the neutrophil-to-lymphocyte ratio (NLR) and derived NLR (dNLR) show nonlinear associations with ACO prevalence among patients with asthma is uncertain. Methods W...

Ru-Yue Jin, Shu-Ni Wang, Jia-Jun Zhang et al. · 0 citations
Open access Oct 2026

Neutrophil-to-lymphocyte ratio as a biomarker associated with chronic obstructive pulmonary disease severity and acute exacerbation

Chronic obstructive pulmonary disease (COPD) is a significant public health issue and ranks among the leading causes of morbidity and mortality globally. This work aimed to examine the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the clinical and functional outcomes of COPD, as well as t...

Tasneem M. M. Abdelfatah, H. Salem, A. S. Elbendary et al. · 0 citations
Open access Sep 2026

One-year progression of CT emphysema subtypes predict lung function decline: SPIROMICS.

One-year progression of CT emphysema subtypes predicted accelerated FEV₁ decline, supporting their potential use as intermediate endpoints in COPD trials and evaluating associations between one-year QCT measure changes and FEV₁ decline from visits two through five.

Emilia A. Hermann, E. Hoffman, Elsa D. Angelini et al. · 0 citations
Oct 2026

Clinical Phenotypes and Prognostic Heterogeneity of Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Prospective Community-Based Cohort Study.

BACKGROUND The clinical phenotypes, prognosis, and heterogeneity of mild-to-moderate chronic obstructive pulmonary disease (COPD) have not been systematically evaluated. RESEARCH QUESTION Do different clinical phenotypes of mild-to-moderate COPD have different prognoses? STUDY DESIGN AND METHODS We analysed the bas...

Fan Wu, Q. Wan, K. Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.